We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Cos. (PDCO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Read MoreHide Full Article
Wall Street analysts expect Patterson Cos. (PDCO - Free Report) to post quarterly earnings of $0.60 per share in its upcoming report, which indicates a year-over-year decline of 3.2%. Revenues are expected to be $1.63 billion, up 2% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Patterson Cos. metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Net sales- Animal Health' to come in at $986.35 million. The estimate suggests a change of +1.8% year over year.
Analysts' assessment points toward 'Net Sales- Animal Health- Consumable' reaching $930.53 million. The estimate indicates a change of +1.1% from the prior-year quarter.
Based on the collective assessment of analysts, 'Net Sales- Animal Health- Equipment and software' should arrive at $37.63 million. The estimate indicates a year-over-year change of +4.4%.
Analysts predict that the 'Net Sales- Animal Health- Value-added services and Other' will reach $18.20 million. The estimate suggests a change of +43.4% year over year.
The consensus estimate for 'Consolidated Net Sales- Consumable- Total' stands at $1.27 billion. The estimate indicates a change of +1.8% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net sales- Corporate' will likely reach $10.30 million. The estimate suggests a change of +6.5% year over year.
It is projected by analysts that the 'Consolidated Net Sales- Value-added services and Other- Total' will reach $106.08 million. The estimate suggests a change of +9% year over year.
The collective assessment of analysts points to an estimated 'Net Sales- Dental supply' of $631.37 million. The estimate indicates a year-over-year change of +1.5%.
According to the collective judgment of analysts, 'Net Sales- Dental supply- Consumable' should come in at $343.09 million. The estimate indicates a change of +3.9% from the prior-year quarter.
Analysts forecast 'Net Sales- Dental supply- Equipment and software' to reach $210.69 million. The estimate suggests a change of -2.8% year over year.
The consensus among analysts is that 'Net sales- Dental supply- Value-added services and other' will reach $77.59 million. The estimate suggests a change of +3.5% year over year.
The average prediction of analysts places 'Consolidated Net Sales- Equipment and Software- Total' at $248.32 million. The estimate indicates a year-over-year change of -1.7%.
Over the past month, shares of Patterson Cos. have returned -6.7% versus the Zacks S&P 500 composite's +5% change. Currently, PDCO carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Cos. (PDCO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect Patterson Cos. (PDCO - Free Report) to post quarterly earnings of $0.60 per share in its upcoming report, which indicates a year-over-year decline of 3.2%. Revenues are expected to be $1.63 billion, up 2% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Patterson Cos. metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Net sales- Animal Health' to come in at $986.35 million. The estimate suggests a change of +1.8% year over year.
Analysts' assessment points toward 'Net Sales- Animal Health- Consumable' reaching $930.53 million. The estimate indicates a change of +1.1% from the prior-year quarter.
Based on the collective assessment of analysts, 'Net Sales- Animal Health- Equipment and software' should arrive at $37.63 million. The estimate indicates a year-over-year change of +4.4%.
Analysts predict that the 'Net Sales- Animal Health- Value-added services and Other' will reach $18.20 million. The estimate suggests a change of +43.4% year over year.
The consensus estimate for 'Consolidated Net Sales- Consumable- Total' stands at $1.27 billion. The estimate indicates a change of +1.8% from the prior-year quarter.
The combined assessment of analysts suggests that 'Net sales- Corporate' will likely reach $10.30 million. The estimate suggests a change of +6.5% year over year.
It is projected by analysts that the 'Consolidated Net Sales- Value-added services and Other- Total' will reach $106.08 million. The estimate suggests a change of +9% year over year.
The collective assessment of analysts points to an estimated 'Net Sales- Dental supply' of $631.37 million. The estimate indicates a year-over-year change of +1.5%.
According to the collective judgment of analysts, 'Net Sales- Dental supply- Consumable' should come in at $343.09 million. The estimate indicates a change of +3.9% from the prior-year quarter.
Analysts forecast 'Net Sales- Dental supply- Equipment and software' to reach $210.69 million. The estimate suggests a change of -2.8% year over year.
The consensus among analysts is that 'Net sales- Dental supply- Value-added services and other' will reach $77.59 million. The estimate suggests a change of +3.5% year over year.
The average prediction of analysts places 'Consolidated Net Sales- Equipment and Software- Total' at $248.32 million. The estimate indicates a year-over-year change of -1.7%.
View all Key Company Metrics for Patterson Cos. here>>>
Over the past month, shares of Patterson Cos. have returned -6.7% versus the Zacks S&P 500 composite's +5% change. Currently, PDCO carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>